[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT895988E - Derivados do acido arilsulfonilamino-hidroxamico - Google Patents

Derivados do acido arilsulfonilamino-hidroxamico

Info

Publication number
PT895988E
PT895988E PT98305959T PT98305959T PT895988E PT 895988 E PT895988 E PT 895988E PT 98305959 T PT98305959 T PT 98305959T PT 98305959 T PT98305959 T PT 98305959T PT 895988 E PT895988 E PT 895988E
Authority
PT
Portugal
Prior art keywords
arylsulphonylamino
aryl
acid derivatives
hydroxamic acid
angiogenisis
Prior art date
Application number
PT98305959T
Other languages
English (en)
Inventor
Ralph Pelton Robinson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT895988E publication Critical patent/PT895988E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
PT98305959T 1997-08-08 1998-07-27 Derivados do acido arilsulfonilamino-hidroxamico PT895988E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5520897P 1997-08-08 1997-08-08

Publications (1)

Publication Number Publication Date
PT895988E true PT895988E (pt) 2002-09-30

Family

ID=21996365

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98305959T PT895988E (pt) 1997-08-08 1998-07-27 Derivados do acido arilsulfonilamino-hidroxamico

Country Status (9)

Country Link
EP (1) EP0895988B1 (pt)
JP (1) JPH11116549A (pt)
AT (1) ATE217863T1 (pt)
BR (1) BR9803128A (pt)
CA (1) CA2244501C (pt)
DE (1) DE69805473T2 (pt)
DK (1) DK0895988T3 (pt)
ES (1) ES2176913T3 (pt)
PT (1) PT895988E (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8469601A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimiento para alquilar sulfonamidas impedidas estericamente
GT199900044A (es) * 1998-04-10 2000-09-14 Procedimientos para preparar haluros de fenoxifenilsulfonilo.
PA8469301A1 (es) 1998-04-10 2000-09-29 Pfizer Prod Inc Procedimientos para la preparacion de acidos hidroxamicos.
AU3196300A (en) * 1999-03-26 2000-10-16 Shionogi & Co., Ltd. Carbocyclic sulfonamide derivatives
DK1041072T3 (da) * 1999-03-31 2003-11-10 Pfizer Prod Inc Dioxocyclopentylhydroxamsyrer
IL138686A0 (en) 1999-10-01 2001-10-31 Pfizer Prod Inc α- SULFONYLAMINO HYDROXAMIC ACID INHIBITORS OF MATRIX METALLOPROTEINASES FOR THE TREATMENT OF PERIPHERAL OR CENTRAL NERVOUS SYSTEM DISORDERS
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
AU2001245891A1 (en) 2000-03-21 2001-10-03 The Procter & Gamble Company Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
IL151250A0 (en) 2000-03-21 2003-04-10 Procter & Gamble Difluorobutyric acid metalloprotease inhibitors
CA2372352A1 (en) * 2000-04-07 2001-10-18 Hyun-Gyu Park Sulfonamide derivative as a matrix metalloproteinase inhibitor
EP1365745A2 (en) 2001-02-15 2003-12-03 King Pharmaceuticals, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US20040235896A1 (en) * 2001-03-14 2004-11-25 Fujimoto Roger Aki Certain azacycloalkyl substituted acetic acid derivatives
KR101038585B1 (ko) 2001-06-26 2011-06-03 암젠 인코포레이티드 Opgl 에 결합하는 항체, 이의 조성물 및 이의 제조방법
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
WO2003042176A1 (fr) * 2001-11-13 2003-05-22 Shiseido Co., Ltd. Compose azabicyclo, inhibiteur de metalloprotease matricielle et preparation cutanee
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
EP1466899A4 (en) 2001-12-27 2010-01-06 Dainippon Sumitomo Pharma Co "HYDROXAMIC ACID DERIVATIVE AND MMP INHIBITOR CONTAINING THEM AS AN ACTIVE SUBSTANCE"
AU2003299971A1 (en) 2002-12-30 2004-07-29 Amgen Inc. Combination therapy with co-stimulatory factors
GB0326546D0 (en) * 2003-11-14 2003-12-17 Amersham Plc Inhibitor imaging agents
ZA200605248B (en) 2003-12-15 2007-10-31 Japan Tobacco Inc Cyclopropane compounds and pharmaceutical use thereof
CA2549598A1 (en) * 2003-12-15 2005-06-30 Japan Tobacco Inc. N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10507158A (ja) * 1994-06-22 1998-07-14 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
SK21499A3 (en) * 1996-08-23 2000-05-16 Pfizer Arylsulfonylamino hydroxamic acid derivatives

Also Published As

Publication number Publication date
DE69805473D1 (de) 2002-06-27
JPH11116549A (ja) 1999-04-27
ATE217863T1 (de) 2002-06-15
ES2176913T3 (es) 2002-12-01
BR9803128A (pt) 2000-05-02
CA2244501C (en) 2003-03-18
DK0895988T3 (da) 2002-09-09
EP0895988B1 (en) 2002-05-22
DE69805473T2 (de) 2003-01-16
EP0895988A1 (en) 1999-02-10
CA2244501A1 (en) 1999-02-08

Similar Documents

Publication Publication Date Title
PT895988E (pt) Derivados do acido arilsulfonilamino-hidroxamico
EP0818442A3 (en) Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
CA2214720A1 (en) Arylsulfonylamino hydroxamic acid derivatives
FR2744010B1 (fr) Procede de fabrication d'implants osseux
EA199900139A1 (ru) Производные арилсульфониламиногидроксамовой кислоты
CA2349227A1 (en) Substituted 2-phenylbenzimidazoles, the production thereof and their use
MY121754A (en) Arylsulfonylamino hydroxamic acid derivatives
DK0738107T3 (da) Inhibitorer for fedtsyresyntese som antimikrobielle midler
NZ330922A (en) Hydroxamic acid derivatives substituted by a series of 2-pyrrolidinones, hydantoins, and pyrazolidinones for use with the treatment of diseases related to connective tissue degradation
GB9902452D0 (en) Chemical compounds
CA2280151A1 (en) Arylsulfonyl hydroxamic acid derivatives
WO1991002716A3 (en) Hydroxamic acid based collagenase inhibitors
ZA987087B (en) Chemical compounds
CA2343204A1 (en) Arylsulfonanilide ureas
PT1049703E (pt) Aldeido do acido n-¬2-(5-benziloxicarbonilamino-6-oxo-2-(4-fluorofenil)-1,6-di-hidro-1-pirimidinil)acetoxil|-l-aspartico como inibidor da enzima de conversao da interleucina-1beta in vivo
WO2003007719A1 (en) Cleansers, cleansing system, bleaching agents and compositions for enviromental conservation
MX9707692A (es) Acido aza bisfosfonicos herbicidas y composiciones que los contienen.
DE69723258D1 (de) Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitoren
BR0100878A (pt) Compostos de hidroxamidas do ácido2-oxo-imidazolidino-4-carboxìlico que inibemmetaloproteinases de matriz
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
WO2000015208A3 (en) New use of immunosupressants for mmp-mediated diseases
PT826681E (pt) Derivados de acido epoxi-succinico
CA2253796A1 (en) Inhibition of matrix metalloproteases by acetylene containing compounds
TW363056B (en) Inhibition of matrix metalloproteases by substituted phenethyl compounds
CA2397960A1 (en) Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith